Stage I-II small-cell lung cancer: Subgroup analysis of the Concurrent Once-daily VErsus twice-daily RadioTherapy (CONVERT) randomized controlled trial
2018
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI